Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / VTVT - Debate Concerning Biogens Alzheimers Drug Approval

VTVT - Debate Concerning Biogens Alzheimers Drug Approval

vTv Therapeutics Inc.

Biogen’s Alzheimer drug Aducanumab was approve amidst much debate. The Food and Drug Administration (FDA) grants accelerated approvals for drugs to treat serious illnesses for which there are no known, or very few, treatments. Was the drug to be marketed as Aduhelm incorrectly made available? Read More >>
Stock Information
Company Name: vTv Therapeutics Inc.
Stock Symbol: VTVT
Market: NASDAQ
Website: vtvtherapeutics.com
Menu
VTVT VTVT Quote VTVT Short VTVT News VTVT Articles VTVT Message Board
Get VTVT Alerts

News, Short Squeeze, Breakout and More Instantly...